JAMA Current Issue

Adjuvant Atezolizumab for Triple-Negative Breast Cancer

This randomized clinical trial investigates whether adding immune therapy to adjuvant chemotherapy for triple-negative breast cancer reduces recurrent disease.

Apr 1, 2025 - 16:46
 0
This randomized clinical trial investigates whether adding immune therapy to adjuvant chemotherapy for triple-negative breast cancer reduces recurrent disease.
Read More

Tags:

Previous Article

CNM-Au8 in Amyotrophic Lateral Sclerosis

Next Article

Point-of-Care Testing to Combat Congenital Syphilis—The Time Is Now

Related Posts

Patient Information: Bedbugs

Feb 25, 2025  0

Newborn Genome Sequencing Screening for Early Actionabl...

Mar 25, 2025  0

FDA Guidance on Pulse Oximetry Testing Among Diverse In...

Feb 18, 2025  0